News
StockStory.org on MSN9d
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With ExpectationsMedical device company ResMed (NYSE:RMD) in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback